UK markets close in 8 hours 12 minutes

Soligenix, Inc. (SNGX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.3960+0.0060 (+1.54%)
At close: 04:00PM EDT
0.4158 +0.02 (+5.00%)
After hours: 07:37PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.3900
Open0.4000
Bid0.3959 x 100
Ask0.4048 x 100
Day's range0.3901 - 0.4099
52-week range0.3700 - 4.2000
Volume97,569
Avg. volume2,728,368
Market cap5.64M
Beta (5Y monthly)1.85
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Benzinga

    Why Is Penny Stock Soligenix Trading Higher On Monday?

    On Monday, Soligenix Inc (NASDAQ:SNGX) received an FDA orphan drug designation for the active ingredient in MarVax, the subunit protein vaccine of recombinantly expressed Marburg marburgvirus (MARV) glycoprotein, for the prevention and post-exposure prophylaxis against MARV infection. In addition to providing a seven-year term of market exclusivity upon final FDA approval, orphan drug designation also positions Soligenix to be able to leverage a wide range of financial and regulatory benefits, i

  • Simply Wall St.

    Here's Why We Think Soligenix, Inc.'s (NASDAQ:SNGX) CEO Compensation Looks Fair

    Key Insights Soligenix will host its Annual General Meeting on 15th of December Total pay for CEO Christopher Schaber...